{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:44:38Z","timestamp":1761489878755},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jval.2015.11.006","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:40:26Z","timestamp":1452213626000},"page":"267-276","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review"],"prefix":"10.1016","volume":"19","author":[{"given":"Maria","family":"Koufopoulou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew John","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Breheny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya","family":"Diwakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2015.11.006_bib1","unstructured":"Global Tuberculosis Report 2014. World Health Organization, Geneva, Switzerland."},{"key":"10.1016\/j.jval.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archinte.1997.00440310087009","article-title":"The cost-effectiveness of preventing tuberculosis in physicians using tuberculin skin testing or a hypothetical vaccine","volume":"157","author":"Nettleman","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11030","article-title":"A systematic review of rapid diagnostic tests for the detection of tuberculosis infection","volume":"11","author":"Dinnes","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jval.2015.11.006_bib4","first-page":"71","article-title":"Current treatment options for latent tuberculosis infection","volume":"91","author":"Bocchino","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jval.2015.11.006_bib5","unstructured":"Centers for Disease and Control Prevention. Latent tuberculosis infection: a guide for primary care providers. Available from: http:\/\/www.cdc.gov\/tb\/publications\/ltbi\/diagnosis.htm. [Accessed December 24, 2015]."},{"key":"10.1016\/j.jval.2015.11.006_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2015.11.006_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3121\/cmr.2.3.191","article-title":"Testing for latent tuberculosis","volume":"2","author":"Ayub","year":"2004","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jval.2015.11.006_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/1817-1737.44778","article-title":"Diagnosis of latent tuberculosis: can we do better?","volume":"4","author":"Al-Orainey","year":"2009","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.jval.2015.11.006_bib9","first-page":"361","article-title":"What is the optimal test for diagnosis of latent tuberculosis?","volume":"50","author":"Moradmand","year":"2012","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.jval.2015.11.006_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.aap.2011.07.004","article-title":"Systematic review and quality assessment of economic evaluation studies of injury prevention","volume":"45","author":"Polinder","year":"2012","journal-title":"Accid Anal Prev"},{"key":"10.1016\/j.jval.2015.11.006_bib11","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"10.1016\/j.jval.2015.11.006_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1258\/135581904322987535","article-title":"Modelling in the economic evaluation of health care: selecting the appropriate approach","volume":"9","author":"Barton","year":"2004","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.jval.2015.11.006_bib13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hec.1485","article-title":"Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic","volume":"19","author":"Lugner","year":"2010","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2015.11.006_bib14","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2015.11.006_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.313.7052.275","article-title":"Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party","volume":"313","author":"Drummond","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jval.2015.11.006_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10198-002-0100-2","article-title":"Developing a scoring system to quality assess economic evaluations","volume":"3","author":"Gonzalez-Perez","year":"2002","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2015.11.006_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","article-title":"Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers","volume":"169","author":"de Perio","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jval.2015.11.006_bib18","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/668436","article-title":"Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers","volume":"33","author":"del Campo","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jval.2015.11.006_bib19","first-page":"471","article-title":"Cost-effectiveness of QuantiFERON-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection","volume":"14","author":"Deuffic-Burban","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1183\/09031936.06.00011806","article-title":"Cost-optimisation of screening for latent tuberculosis in close contacts","volume":"28","author":"Diel","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jval.2015.11.006_bib21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1378\/chest.06-2728","article-title":"Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany","volume":"131","author":"Diel","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.jval.2015.11.006_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1183\/09031936.00145906","article-title":"Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis","volume":"30","author":"Diel","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jval.2015.11.006_bib23","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.rmed.2009.07.008","article-title":"Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany","volume":"103","author":"Diel","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jval.2015.11.006_bib24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/thx.2009.119677","article-title":"Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries","volume":"65","author":"Hardy","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.jval.2015.11.006_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/phn.12083","article-title":"Cost-effectiveness of using Quantiferon Gold (QFT-G) (R) versus tuberculin skin test (TST) among U.S. and foreign born populations at a public health department clinic with a low prevalence of tuberculosis","volume":"31","author":"Iqbal","year":"2014","journal-title":"Public Health Nurs"},{"key":"10.1016\/j.jval.2015.11.006_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF03256289","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan","volume":"12","author":"Kowada","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jval.2015.11.006_bib27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF03256394","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-alpha antagonist therapy","volume":"14","author":"Kowada","year":"2010","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jval.2015.11.006_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03262207","article-title":"Cost effectiveness of interferon-gamma release assay for school-based tuberculosis screening","volume":"16","author":"Kowada","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.jval.2015.11.006_bib29","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1017\/S0950268812002907","article-title":"Cost-effectiveness of interferon-gamma release assay for entry tuberculosis screening in prisons","volume":"141","author":"Kowada","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jval.2015.11.006_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfs479","article-title":"Cost effectiveness of the interferon-gamma release assay for tuberculosis screening of hemodialysis patients","volume":"28","author":"Kowada","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jval.2015.11.006_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinf.2013.08.009","article-title":"Cost effectiveness of interferon-gamma release assay for TB screening of HIV positive pregnant women in low TB incidence countries","volume":"68","author":"Kowada","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.jval.2015.11.006_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jhin.2014.10.002","article-title":"Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries","volume":"89","author":"Kowada","year":"2015","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jval.2015.11.006_bib33","doi-asserted-by":"crossref","first-page":"857","DOI":"10.5588\/ijtld.14.0518","article-title":"Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke","volume":"19","author":"Kowada","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/j.ajkd.2012.06.004","article-title":"Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children","volume":"61","author":"Laskin","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib35","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.201101-0181OC","article-title":"Priorities for screening and treatment of latent tuberculosis infection in the United States","volume":"184","author":"Linas","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jval.2015.11.006_bib36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.5588\/ijtld.10.0542","article-title":"Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis","volume":"15","author":"Mancuso","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2011-200933","article-title":"Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting","volume":"68","author":"Mandalakas","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jval.2015.11.006_bib38","first-page":"1414","article-title":"Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts","volume":"12","author":"Marra","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib39","first-page":"16","article-title":"Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis","volume":"11","author":"Oxlade","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/thoraxjnl-2011-201542","article-title":"Community-based evaluation of immigrant tuberculosis screening using interferon gamma release assays and tuberculin skin testing: observational study and economic analysis","volume":"68","author":"Pareek","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jval.2015.11.006_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2466-10-7","article-title":"Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis","volume":"10","author":"Pooran","year":"2010","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jval.2015.11.006_bib42","doi-asserted-by":"crossref","first-page":"e36551","DOI":"10.1371\/journal.pone.0036551","article-title":"Programmatic impact of QuantiFERON-TB Gold In-Tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic","volume":"7","author":"Shah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2015.11.006_bib43","doi-asserted-by":"crossref","first-page":"e59546","DOI":"10.1371\/journal.pone.0059546","article-title":"Cost-effectiveness of Quantiferon(R)-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil","volume":"8","author":"Steffen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2015.11.006_bib44","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/MIB.0b013e31829f008f","article-title":"Cost-effectiveness of QuantiFERON testing before initiation of biological therapy in inflammatory bowel disease","volume":"19","author":"Swaminath","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2015.11.006_bib46","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jval.2015.11.006_bib47","doi-asserted-by":"crossref","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2015.11.006_bib48","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jval.2015.11.006_bib49","doi-asserted-by":"crossref","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515051268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515051268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:54:27Z","timestamp":1718301267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301515051268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1098301515051268"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2015.11.006","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}